DARMSTADT, Germany--(BUSINESS WIRE)--Merck Serono, the biopharmaceutical business of Merck, today announced the appointment of Alise Reicin, MD, as Senior Vice President, Head of Global Clinical Development. Dr. Reicin brings extensive research and early/late clinical development expertise to Merck Serono, including experience in Oncology and Immunology. She is an accomplished pharmaceutical executive with strong leadership ability, having served as a Vice President in various capacities across R&D at MSD (Merck Sharp & Dohme) for the last 10 years.
Help employers find you! Check out all the jobs and post your resume.
